GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Illumina, Inc. (ILMN) [hlAlert]

Rating:
Outperform
ILMN
up 207.08 %

Illumina, Inc. (ILMN) rated Outperform by William Blair

Posted on: Friday,  Jan 7, 2011  2:25 PM ET by William Blair

William Blair rated Outperform Illumina, Inc. (NASDAQ: ILMN) on 01/07/2011, when the stock price was $65.76. Since
then, Illumina, Inc. has gained 207.09% as of 01/26/2016's recent price of $201.94.
If you would have followed this William Blair's recommendation on ILMN, you would have gained 207.08% of your investment in 1845 days.

Illumina, Inc. is a developer, manufacturer and marketer of integrated systems for the large-scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that serve the sequencing, genotyping and gene expression markets. It also, develops and commercializes sequencing technologies used to perform a range of analyses, including whole genome re-sequencing, gene expression analysis and small ribonucleic acid (RNA) analysis. Its customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies. The Company operates in two business segments: Life Sciences and Diagnostics. On August 1, 2008, the Company acquired Avantome, Inc. The Company?s subsidiary is Solexa, Inc.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/7/2011 2:25 PM Buy
None
65.76
as of 12/30/2011
1 Week up  4.74 %
1 Month up  9.56 %
3 Months down  -25.51 %
1 YTD down  -53.64 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy